LANCET ONCOLOGY

Lancet Oncology, identified by the ISSN 1470-2045, is a prestigious international journal published monthly by Elsevier in the United Kingdom, serving as a leading platform for high-impact research in the field of oncology. As a highly cited publication indexed in the Science Citation Index (SCI), it consistently ranks within the top tiers of the Chinese Academy of Sciences journal classification, typically securing a position in the first or second quartile of the medical sciences category. The journal focuses on rigorous clinical and translational studies, encompassing a broad spectrum of topics from cancer prevention, diagnosis, and therapeutic strategies to fundamental biological mechanisms, with a particular emphasis on multidisciplinary approaches and cutting-edge advancements. While not fully open access, it offers partial open options and is renowned for its stringent peer-review process, which contributes to its strong reputation but also results in high competition and relatively high rejection rates. Although authors may encounter challenges such as extended review periods and significant article processing charges, Lancet Oncology remains a premier venue for researchers seeking to disseminate influential work to a global audience of clinicians, scientists, and policymakers in the oncology community.